Browse

Full access

HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Full access

HSR21-068: Predicting Preventable Emergency Department Visits and Admissions After Chemotherapy

Full access

HSR21-069: Factors Associated With Time to Treatment With an EGFR-TKI Among Patients With Non-Squamous Metastatic Non-Small Cell Lung Cancer: A SEER-Medicare Analysis

Full access

HSR21-070: Feasibility of Tracking Digital Activity, Sleep, and Patient-Reported Outcomes (PROs) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Undergoing an In-Class Transition From Parenteral Bortezomib-Based Therapy to Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) in the Ongoing Community-Based United States (US) MM-6 Study (NCT03173092)

Full access

HSR21-071: Healthcare Utilization Between Blood and Solid Cancer Survivors and Implications for Financial Toxicity: Results From the National Health Interview Survey, 2009-2018

Full access

HSR21-072: Neoadjuvant Chemotherapy in Breast Cancer Care: Does Equal Access Mitigate Racial Disparities?

Full access

HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial and Medicare Claims From 2017-2018

Full access

HSR21-074: Respiratory Viral Infections Continue to be an Unresolved Problem in the Care of Immunocompromised Transplant Patients

Full access

HSR21-075: CancerSupportSource®-Caregiver: Psychometric Properties of 2-Item Depression and Anxiety Risk Screening Measures for Informal Cancer Caregivers

Full access

HSR21-076: Valued Outcomes in the Cancer Experience (VOICE™): Developing and Validating a Measure of Patient Experience

Filter

You are looking at 81 - 90 of 3,328 items for

HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

HSR21-068: Predicting Preventable Emergency Department Visits and Admissions After Chemotherapy

HSR21-069: Factors Associated With Time to Treatment With an EGFR-TKI Among Patients With Non-Squamous Metastatic Non-Small Cell Lung Cancer: A SEER-Medicare Analysis

HSR21-071: Healthcare Utilization Between Blood and Solid Cancer Survivors and Implications for Financial Toxicity: Results From the National Health Interview Survey, 2009-2018

HSR21-072: Neoadjuvant Chemotherapy in Breast Cancer Care: Does Equal Access Mitigate Racial Disparities?

HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial and Medicare Claims From 2017-2018

HSR21-074: Respiratory Viral Infections Continue to be an Unresolved Problem in the Care of Immunocompromised Transplant Patients

HSR21-075: CancerSupportSource®-Caregiver: Psychometric Properties of 2-Item Depression and Anxiety Risk Screening Measures for Informal Cancer Caregivers

HSR21-076: Valued Outcomes in the Cancer Experience (VOICE™): Developing and Validating a Measure of Patient Experience

Filter Filter

Browse

You are looking at 81 - 90 of 3,328 items for

Filter